In February 2026, Silk Road Fund committed to invest in Helios Fund V. The fund is managed by Helios Investment Partners, an African private equity firm, with a strategic focus on leading companies that benefit from the confluence of technological innovation and Africa’s dynamic demographic and urbanization trends. This investment helps enhance the well-being of African people and promote the sustainable development of local communities, demonstrating positive social and livelihood value.

In February 2026, Silk Road Fund and Macquarie Capital jointly acquired Renewi, a leading integrated waste management company in the Benelux region (Belgium, Netherlands, Luxembourg). Renewi collects and sorts over 10 million tons of various types of waste annually, effectively improving local waste recycling rates. It also helps reduce carbon dioxide emissions from waste incineration, contributing to the achievement of EU 2050 net-zero target.

In February 2026, Silk Road Fund invested in a cross-border subsea interconnector asset in Ireland jointly with Equitix, a leading UK-based infrastructure fund manager. The asset owns and operates the subsea interconnector linking Ireland and the United Kingdom, together with its associated converter stations. It helps strengthen regional grid resilience and enhance renewable energy integration, serving as critical infrastructure for advancing climate mitigation goals and ensuring stable power supply.

In February 2026, Silk Road Fund and Quadria Capital, a healthcare-focused private equity fund in Southeast Asia, jointly completed the privatization and acquisition of Apex Healthcare, a leading private pharmaceutical company in Malaysia. As the third largest pharmaceutical firm in the country, Apex Healthcare both manufactures and distributes pharmaceutical and healthcare products. This investment helps enhance Southeast Asian people’s access to medicines, improving their well-being and continuously advancing the Health Silk Road.